Clinical Trials Directory

Trials / Completed

CompletedNCT01703884

ANC & Malaria Diagnostic in Pregnancy

Improved Quality of ANC and Diagnostic Services for Malaria in Pregnancy

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
5,254 (actual)
Sponsor
Centre Muraz · Academic / Other
Sex
Female
Age
16 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The program's overall objective is to assess the impact of a package of interventions aimed at reducing malaria-related mortality and morbidity in pregnant women and newborns by ensuring access to a package of interventions designed to optimise the detection and treatment of malaria during pregnancy as well as improving the early detection and treatment of malaria during the third trimester.

Detailed description

This is a cluster-randomised study in which the health facility is the unit of randomisation. 16 health facilities will be randomised to intervention and control. At the community level women will be encouraged to access ANC early in the pregnancy, attend follow-up antenatal visits throughout the pregnancy and deliver at the facility. The current recommended standard of care will be provided to all women attending antenatal and obstetric care. In the intervention area, obstetric, medical, drug-exposure histories will be collected at ANC visits. In addition, in the last trimester of the pregnancy (\> 28 weeks of pregnancy), women will be systematically evaluated with selected diagnostic test for whether they have malaria parasites and treated effectively. Skilled birth attendants at the facility will be trained in emergency obstetric and neonatal care and the assessment of neonates for danger signs, low birth weight and external/observable birth defects. In the control area, women will be provided with standard practice of care. In both areas, women will be diagnosed and treated at delivery if they are positive.

Conditions

Interventions

TypeNameDescription
DRUGASAQIn the intervention area, obstetric, medical, drug-exposure histories will be collected at ANC visits. In addition, in the last trimester of the pregnancy (\> 28 weeks of pregnancy), women will be systematically evaluated with malaria RDT for whether they have malaria parasites and treated effectively with ASAQ.

Timeline

Start date
2012-08-01
Primary completion
2014-07-01
Completion
2014-12-01
First posted
2012-10-11
Last updated
2015-07-31

Locations

1 site across 1 country: Burkina Faso

Source: ClinicalTrials.gov record NCT01703884. Inclusion in this directory is not an endorsement.